Complete Filing Data
Zentalis Pharmaceuticals, Inc. reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $216.20 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Zentalis Pharmaceuticals, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$137.1M | -$165.8M | -$292.2M | -$236.8M | -$158.7M | -$117.8M | -$45.7M |
| Research And Development Expense | $107.3M | $167.8M | $189.6M | $172.7M | $175.6M | $84.9M | $38.4M |
| Operating Income Loss | -$152.8M | -$191.2M | -$299.5M | -$227.3M | -$216.5M | -$118.8M | -$46.8M |
| Operating Expenses | $152.8M | $258.6M | $299.5M | $227.3M | $216.5M | $118.8M | $46.8M |
| Net Income Loss Attributable To Noncontrolling Interest | $0.00 | -$28.0K | -$114.0K | -$307.0K | -$7.4M | -$707.0K | -$715.0K |
| Income Tax Expense Benefit | $442.0K | $177.0K | -$601.0K | -$469.0K | -$297.0K | $444.0K | $15.0K |
| General And Administrative Expense | $37.7M | $87.1M | $64.4M | $54.6M | $40.9M | $33.9M | $8.5M |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -$362.0K | -$1.6M | $3.5M | -$1.2M | -$161.0K | $36.0K | $0.00 |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$137.4M | -$167.5M | -$288.8M | -$238.3M | -$166.3M | -$118.5M | -$46.4M |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $0.00 | -$28.0K | -$114.0K | -$307.0K | -$7.4M | -$707.0K | -$715.0K |
| Comprehensive Income Net Of Tax | -$137.4M | -$167.5M | -$288.6M | -$238.0M | -$158.9M | -$117.8M | -$45.7M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$362.0K | -$1.6M | $3.5M | -$1.2M | -$161.0K | $36.0K | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$164.6M | -$118.1M | -$46.4M | ||||
| Income Loss From Equity Method Investments | $0.00 | $0.00 | -$16.0M | -$16.3M | -$1.8M | $0.00 | $0.00 |
| Deferred Income Tax Liabilities Net | $0.00 | $853.0K | $1.6M | $2.5M | $2.5M | ||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | -$136.6M | -$165.7M | -$276.9M | -$221.3M | -$164.6M | -$118.1M | |
| Revenue From Contract With Customer Excluding Assessed Tax | $0.00 | $67.4M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$26.7M | -$26.9M | -$48.3M | -$40.2M | -$88.3M | $10.1M | -$55.5M | -$112.5M | -$63.2M | -$54.4M | -$68.4M | -$59.1M | -$50.1M | -$4.2M | -$54.6M | -$49.9M | -$40.3M | -$34.6M | -$26.9M | -$16.1M | -$14.5M | -$12.3M | -$10.5M | -$8.3M |
| Research And Development Expense | $23.0M | $27.6M | $27.2M | $36.8M | $48.4M | $49.6M | $46.8M | $42.7M | $48.6M | $42.2M | $43.8M | $46.1M | $38.4M | $54.0M | $44.8M | $38.4M | $29.5M | $24.7M | $17.5M | $13.3M | $11.9M | $10.7M | $8.7M | $7.1M |
| Operating Income Loss | -$33.7M | -$36.1M | -$45.6M | -$51.4M | -$65.1M | -$24.8M | -$62.7M | -$103.9M | -$65.0M | -$54.2M | -$63.5M | -$57.9M | -$48.2M | -$62.9M | -$55.1M | -$50.3M | -$40.2M | -$34.8M | -$27.4M | -$16.4M | -$14.9M | -$12.6M | -$10.6M | -$8.7M |
| Operating Expenses | $33.7M | $36.1M | $45.6M | $51.4M | $65.1M | $65.3M | $62.7M | $103.9M | $65.0M | $54.2M | $63.5M | $57.9M | $48.2M | $62.9M | $55.1M | $50.3M | $40.2M | $34.8M | $27.4M | $16.4M | $14.9M | $12.6M | $10.6M | $8.7M |
| Net Income Loss Attributable To Noncontrolling Interest | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$28.0K | -$12.0K | -$37.0K | -$43.0K | -$99.0K | -$35.0K | -$160.0K | -$36.0K | -$6.3M | -$488.0K | -$543.0K | -$53.0K | -$110.0K | -$435.0K | -$109.0K | -$40.0K | -$228.0K | -$127.0K | -$320.0K |
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | -$27.0K | $266.0K | $143.0K | $31.0K | -$605.0K | $108.0K | -$159.0K | $17.0K | $33.0K | $159.0K | -$697.0K | $45.0K | $196.0K | $426.0K | $18.0K | $0.00 | $0.00 | $0.00 | $1.0K | $11.0K | $3.0K |
| General And Administrative Expense | $10.8M | $8.4M | $10.6M | $14.6M | $16.8M | $15.7M | $16.0M | $15.7M | $16.4M | $12.0M | $19.6M | $11.8M | $9.8M | $8.9M | $10.4M | $12.0M | $10.7M | $10.1M | $9.9M | $3.1M | $3.0M | $1.8M | $1.9M | $1.6M |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $127.0K | -$299.0K | -$200.0K | $1.5M | -$633.0K | -$1.4M | -$21.0K | $218.0K | $797.0K | -$491.0K | -$670.0K | -$984.0K | -$17.0K | -$1.0K | $14.0K | $19.0K | $4.0K | $0.00 | $0.00 | $0.00 | ||||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$26.6M | -$27.2M | -$48.5M | -$38.7M | -$88.9M | $8.6M | -$55.6M | -$112.3M | -$62.5M | -$55.0M | -$69.1M | -$60.2M | -$10.6M | -$55.0M | -$50.4M | -$34.6M | -$27.3M | -$16.2M | -$12.6M | -$10.6M | ||||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$28.0K | -$12.0K | -$37.0K | -$43.0K | -$99.0K | -$35.0K | -$160.0K | -$6.3M | -$488.0K | -$543.0K | -$110.0K | -$435.0K | -$109.0K | -$228.0K | |||||
| Comprehensive Income Net Of Tax | -$26.6M | -$27.2M | -$48.5M | -$38.7M | -$88.9M | $8.6M | -$55.5M | -$112.3M | -$62.4M | -$54.9M | -$69.0M | -$60.1M | -$4.3M | -$54.5M | -$49.9M | -$34.5M | -$26.9M | -$16.1M | -$12.3M | |||||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $127.0K | -$299.0K | -$200.0K | $1.5M | -$633.0K | -$1.4M | -$21.0K | $218.0K | $797.0K | -$491.0K | -$670.0K | -$984.0K | -$62.0K | $44.0K | $14.0K | $19.0K | $4.0K | |||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$26.7M | -$26.9M | -$48.3M | -$40.2M | -$88.0M | $10.2M | -$52.3M | -$63.0M | -$57.5M | -$48.1M | -$11.2M | -$55.0M | -$50.2M | -$39.9M | -$34.6M | -$27.3M | -$16.2M | -$14.5M | -$12.6M | -$10.6M | -$8.7M | |||
| Income Loss From Equity Method Investments | $0.00 | $0.00 | $0.00 | $0.00 | -$13.7M | -$2.3M | -$2.4M | -$5.3M | -$1.8M | -$1.8M | $0.00 | $0.00 | $0.00 | |||||||||||
| Deferred Income Tax Liabilities Net | $0.00 | $0.00 | $756.0K | $1.2M | $1.3M | $1.5M | $1.7M | $2.5M | $2.5M | $2.5M | $2.5M | $2.5M | ||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | -$40.2M | -$88.0M | $10.2M | -$55.5M | -$99.5M | -$60.8M | -$52.3M | -$63.0M | -$57.5M | |||||||||||||||
| Revenue From Contract With Customer Excluding Assessed Tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $40.6M | $0.00 | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $216.2M | $337.2M | $437.3M | $433.8M | $364.5M | $333.4M | -$73.3M | $32.3M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $38.6M | $36.5M | $30.7M | $45.7M | $62.6M | $56.3M | $67.5M | $25.2M |
| Cash And Cash Equivalents At Carrying Value | $36.0M | $33.9M | $28.0M | $43.1M | $59.7M | $55.0M | $67.2M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $2.1M | $5.8M | -$15.0M | -$16.9M | $6.3M | -$11.2M | $42.3M | |
| Retained Earnings Accumulated Deficit | -$1.19B | -$1.05B | -$888.6M | -$596.4M | -$359.6M | -$200.8M | -$83.0M | |
| Property Plant And Equipment Net | $2.8M | $4.7M | $5.8M | $7.7M | $8.1M | $1.1M | $501.0K | |
| Prepaid Expense And Other Assets Noncurrent | $4.1M | $4.4M | $6.8M | $9.7M | $7.0M | $3.0M | $2.1M | |
| Prepaid Expense And Other Assets Current | $7.3M | $10.0M | $13.8M | $14.6M | $10.6M | $6.2M | $1.5M | |
| Liabilities Current | $36.6M | $52.7M | $69.4M | $56.6M | $43.9M | $28.6M | $14.9M | |
| Liabilities And Stockholders Equity | $289.0M | $430.3M | $551.7M | $539.3M | $454.5M | $365.6M | $87.5M | |
| Liabilities | $72.8M | $93.2M | $114.3M | $105.3M | $90.0M | $32.2M | $19.1M | |
| Assets Current | $253.2M | $386.1M | $496.7M | $451.9M | $350.8M | $345.1M | $68.9M | |
| Assets | $289.0M | $430.3M | $551.7M | $539.3M | $454.5M | $365.6M | $87.5M | |
| Accrued Liabilities Current | $29.4M | $45.3M | $54.4M | $45.4M | $32.4M | $19.9M | $10.6M | |
| Accounts Payable Current | $7.2M | $7.4M | $14.9M | $11.2M | $11.6M | $8.7M | $4.3M | |
| Operating Lease Right Of Use Asset | $26.3M | $32.5M | $35.9M | $42.4M | $44.7M | $2.5M | $2.3M | |
| Other Liabilities Noncurrent | $500.0K | $849.0K | $1.8M | $2.6M | $0.00 | $1.7M | ||
| Restricted Cash Noncurrent | $2.6M | $2.6M | $2.7M | $2.6M | $2.6M | $1.3M | $243.0K | |
| Common Stock Value | $69.0K | $71.0K | $70.0K | $59.0K | $45.0K | $41.0K | ||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $196.0K | $558.0K | $2.2M | -$1.4M | -$125.0K | $36.0K | ||
| Goodwill | $0.00 | $3.7M | $3.7M | $3.7M | $3.7M | $3.7M | ||
| Gain Loss On Sale Of Property Plant Equipment | $660.0K | $13.0K | -$406.0K | -$56.0K | -$15.0K | $0.00 | $0.00 | |
| Restricted Cash | $243.0K | |||||||
| Accretion Amortization Of Discounts And Premiums Investments | $2.8M | $8.0M | $13.2M | $3.7M | -$908.0K | -$556.0K | ||
| Accounts Receivable Net Current | $0.00 | $5.0M | $0.00 | $4.0K | $417.0K | $140.0K | ||
| Operating Lease Liability Noncurrent | $35.7M | $39.6M | $43.2M | $45.2M | $44.5M | $1.1M | ||
| Minority Interest | $0.00 | $107.0K | $221.0K | |||||
| Available For Sale Securities Debt Securities | $454.9M | $394.3M | $280.2M | $283.6M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $252.9M | $274.5M | $295.4M | $354.3M | $382.6M | $458.8M | $481.8M | $523.1M | $385.5M | $428.5M | $472.5M | $315.3M | $364.0M | $393.4M | $223.8M | $268.4M | $308.6M | $365.8M | $237.9M | -$89.2M | -$59.0M | $13.3M | $23.8M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $41.7M | $40.2M | $44.6M | $43.9M | $39.7M | $40.3M | $113.4M | $269.2M | $38.9M | $45.2M | $57.8M | $33.4M | $44.1M | $52.4M | $32.3M | $93.9M | $96.4M | $64.1M | $80.8M | $9.0M | $16.1M | |||
| Cash And Cash Equivalents At Carrying Value | $39.1M | $37.6M | $41.9M | $41.3M | $37.0M | $37.6M | $110.8M | $266.6M | $36.3M | $42.6M | $55.1M | $30.6M | $40.8M | $49.2M | $29.0M | $92.6M | $96.0M | $63.7M | $80.5M | $8.7M | $16.1M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $8.0M | $9.6M | -$6.8M | -$29.1M | -$24.0M | -$3.4M | -$9.0M | |||||||||||||||||
| Retained Earnings Accumulated Deficit | -$1.16B | -$1.13B | -$1.10B | -$1.01B | -$966.8M | -$878.5M | -$827.6M | -$772.1M | -$659.6M | -$541.4M | -$487.0M | -$418.6M | -$309.5M | -$305.3M | -$250.7M | -$160.5M | -$126.0M | -$99.1M | ||||||
| Property Plant And Equipment Net | $2.9M | $3.1M | $3.2M | $5.0M | $5.3M | $5.7M | $6.4M | $6.7M | $6.9M | $8.0M | $8.2M | $8.5M | $4.7M | $2.3M | $1.5M | $471.0K | $481.0K | $519.0K | ||||||
| Prepaid Expense And Other Assets Noncurrent | $3.2M | $3.2M | $3.3M | $5.6M | $6.8M | $6.9M | $8.5M | $7.9M | $9.5M | $10.2M | $11.9M | $10.2M | $6.0M | $4.8M | $2.8M | $4.2M | $3.2M | $2.4M | ||||||
| Prepaid Expense And Other Assets Current | $7.6M | $8.2M | $10.4M | $9.0M | $13.2M | $14.8M | $11.6M | $10.9M | $17.7M | $12.2M | $12.4M | $11.7M | $10.4M | $8.3M | $7.7M | $5.2M | $5.2M | $2.2M | ||||||
| Liabilities Current | $37.2M | $39.0M | $49.4M | $54.9M | $66.7M | $54.8M | $58.9M | $51.8M | $56.4M | $54.1M | $48.6M | $43.5M | $39.4M | $33.6M | $32.8M | $23.9M | $15.6M | $16.9M | ||||||
| Liabilities And Stockholders Equity | $327.3M | $351.7M | $384.0M | $450.7M | $491.7M | $557.5M | $585.7M | $621.4M | $489.3M | $529.2M | $567.9M | $405.7M | $435.1M | $284.0M | $328.4M | $393.2M | $257.2M | $87.6M | ||||||
| Liabilities | $74.4M | $77.2M | $88.6M | $96.3M | $109.1M | $98.7M | $103.8M | $98.2M | $103.7M | $100.5M | $95.0M | $90.0M | $41.1M | $36.4M | $35.7M | $27.4M | $19.3M | $20.9M | ||||||
| Assets Current | $288.3M | $311.6M | $342.9M | $400.3M | $439.6M | $503.8M | $528.3M | $563.9M | $410.2M | $433.9M | $467.6M | $301.3M | $377.6M | $259.4M | $306.4M | $372.7M | $238.5M | $66.0M | ||||||
| Assets | $327.3M | $351.7M | $384.0M | $450.7M | $491.7M | $557.5M | $585.7M | $621.4M | $489.3M | $529.2M | $567.9M | $405.7M | $435.1M | $284.0M | $328.4M | $393.2M | $257.2M | $87.6M | ||||||
| Accrued Liabilities Current | $30.1M | $35.3M | $41.7M | $46.7M | $46.3M | $44.3M | $44.7M | $39.5M | $43.5M | $44.2M | $36.6M | $30.3M | $31.4M | $25.3M | $24.5M | $18.5M | $11.4M | $9.9M | ||||||
| Accounts Payable Current | $7.0M | $3.7M | $7.8M | $8.2M | $20.4M | $10.5M | $14.3M | $12.3M | $12.8M | $9.8M | $12.0M | $13.2M | $8.0M | $8.3M | $8.3M | $5.4M | $4.2M | $7.0M | ||||||
| Operating Lease Right Of Use Asset | $30.2M | $31.2M | $31.9M | $33.4M | $33.5M | $34.7M | $36.2M | $36.6M | $37.5M | $42.6M | $43.3M | $43.6M | $693.0K | $1.2M | $1.9M | $1.9M | $2.1M | $2.3M | ||||||
| Other Liabilities Noncurrent | $500.0K | $500.0K | $558.0K | $996.0K | $1.1M | $1.3M | $1.6M | $2.4M | $1.8M | $45.2M | $45.1M | $45.0M | $0.00 | $296.0K | $438.0K | $1.1M | $1.0M | $1.3M | $1.5M | |||||
| Restricted Cash Noncurrent | $2.6M | $2.6M | $2.6M | $2.6M | $2.7M | $2.7M | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $3.0M | $3.0M | ||||||||||
| Common Stock Value | $72.0K | $72.0K | $72.0K | $71.0K | $71.0K | $70.0K | $70.0K | $70.0K | $59.0K | $57.0K | $57.0K | $46.0K | $45.0K | $41.0K | $41.0K | $41.0K | $36.0K | $0.00 | ||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $186.0K | $59.0K | $358.0K | $1.6M | $140.0K | $773.0K | -$359.0K | -$338.0K | -$556.0K | -$2.3M | -$1.8M | -$1.1M | $32.0K | $94.0K | $50.0K | $23.0K | $4.0K | $0.00 | ||||||
| Goodwill | $3.7M | $3.7M | $3.7M | $3.7M | $3.7M | $3.7M | $3.7M | $3.7M | $3.7M | $3.7M | $3.7M | $3.7M | $3.7M | $3.7M | $3.7M | |||||||||
| Gain Loss On Sale Of Property Plant Equipment | $0.00 | $66.0K | $0.00 | $0.00 | -$15.0K | |||||||||||||||||||
| Restricted Cash | $2.6M | $2.6M | $2.6M | $2.6M | $2.7M | $2.7M | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $2.9M | $3.3M | $3.3M | $3.3M | $1.3M | $1.3M | $411.0K | $411.0K | |||||
| Accretion Amortization Of Discounts And Premiums Investments | $1.0M | $2.8M | $3.3M | -$146.0K | ||||||||||||||||||||
| Accounts Receivable Net Current | $0.00 | $0.00 | $0.00 | $108.0K | $5.0K | $248.0K | $122.0K | $73.0K | $139.0K | |||||||||||||||
| Operating Lease Liability Noncurrent | $36.7M | $37.7M | $38.7M | $40.5M | $41.3M | $42.6M | $43.3M | $44.0M | $44.8M | |||||||||||||||
| Minority Interest | $0.00 | $0.00 | $0.00 | $129.0K | $141.0K | $178.0K | $234.0K | $333.0K | $368.0K | $528.0K | $564.0K | $23.8M | $24.3M | $24.8M | ||||||||||
| Available For Sale Securities Debt Securities | $405.9M | $286.4M | $356.2M | $379.2M | $400.1M | $258.8M | $326.0M | $201.7M | $274.9M | $137.2M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Depreciation Depletion And Amortization | $739.0K | $1.3M | $1.4M | $1.4M | $544.0K | $160.0K | $111.0K |
| Share Based Compensation | $20.7M | $67.3M | $54.8M | $46.8M | $35.7M | $23.1M | $617.0K |
| Payments To Acquire Property Plant And Equipment | $0.00 | $221.0K | $583.0K | $2.5M | $6.1M | $758.0K | $352.0K |
| Net Cash Provided By Used In Operating Activities | -$125.2M | -$170.9M | -$207.8M | -$163.8M | -$154.1M | -$86.8M | -$39.1M |
| Net Cash Provided By Used In Investing Activities | $131.6M | $176.6M | -$44.5M | -$114.2M | -$18.1M | -$284.8M | -$352.0K |
| Net Cash Provided By Used In Financing Activities | -$4.3M | $108.0K | $237.3M | $261.0M | $178.5M | $360.4M | $81.8M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$3.0M | -$6.2M | $5.7M | $6.6M | -$1.3M | $5.8M | $1.5M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$17.3M | -$18.0M | $10.9M | $15.5M | $14.0M | $14.3M | $7.1M |
| Increase Decrease In Operating Lease Right Of Use Assets And Liabilities Net | $201.0K | $264.0K | $623.0K | $4.3M | $1.3M | -$667.0K | $115.0K |
| Payments To Acquire Available For Sale Securities Debt | $139.5M | $128.0M | $549.2M | $533.2M | $363.5M | $401.0M | $0.00 |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $250.0M | $271.2M | $505.3M | $421.5M | $365.8M | $116.9M | $0.00 |
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 304.0K | 349.0K | 1.6M | 3.1M | 7.7M | 0.00 | 0.00 |
| Proceeds From Issuance Of Common Stock | $5.4M | $0.00 | $235.7M | $257.9M | $172.0M | $155.3M | $0.00 |
| Increase Decrease In Accounts Receivable | -$5.0M | $5.0M | $0.00 | $0.00 | -$413.0K | $277.0K | -$777.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation Depletion And Amortization | $160.0K | $160.0K | $262.0K | $321.0K | $327.0K | $324.0K | $348.0K | $344.0K | $360.0K | $375.0K | $348.0K | $344.0K | $137.0K | $119.0K | $79.0K | $51.0K | $38.0K | $38.0K | $25.0K | $24.0K | $21.0K |
| Share Based Compensation | $6.5M | $12.8M | $13.7M | $10.1M | $9.7M | $329.0K | $129.0K | ||||||||||||||
| Payments To Acquire Property Plant And Equipment | $0.00 | $40.0K | $0.00 | $450.0K | $436.0K | $31.0K | $41.0K | ||||||||||||||
| Net Cash Provided By Used In Operating Activities | -$32.6M | -$52.0M | -$49.3M | -$50.2M | -$37.5M | -$16.9M | -$9.0M | ||||||||||||||
| Net Cash Provided By Used In Investing Activities | $40.5M | $61.5M | $42.1M | $19.8M | $13.5M | -$31.0K | -$41.0K | ||||||||||||||
| Net Cash Provided By Used In Financing Activities | $189.0K | $7.0K | $373.0K | $1.3M | $0.00 | $13.5M | $0.00 | ||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$663.0K | $1.1M | $2.9M | $4.2M | $1.4M | $1.1M | $230.0K | ||||||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$4.0M | -$15.2M | -$1.4M | -$500.0K | $3.3M | $53.0K | -$467.0K | ||||||||||||||
| Increase Decrease In Operating Lease Right Of Use Assets And Liabilities Net | $114.0K | $772.0K | $309.0K | $1.4M | $782.0K | -$7.0K | -$21.0K | ||||||||||||||
| Payments To Acquire Available For Sale Securities Debt | $19.5M | $10.1M | $63.9M | $79.3M | $54.4M | $0.00 | |||||||||||||||
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $60.0M | $71.7M | $106.0M | $99.5M | $68.3M | $0.00 | |||||||||||||||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 189.0K | 248.0K | 373.0K | 1.3M | 0.00 | ||||||||||||||||
| Proceeds From Issuance Of Common Stock | |||||||||||||||||||||
| Increase Decrease In Accounts Receivable | $0.00 | -$169.0K | -$1.0K | -$225.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.91 | -$2.33 | -$4.47 | -$4.48 | -$3.72 | -$4.19 | -$8.16 | |
| Weighted Average Number Of Shares Outstanding Basic | 71.9M | 71.1M | 65.4M | 52.9M | 42.7M | 28.1M | 5.6M | |
| Weighted Average Number Of Diluted Shares Outstanding | 71.9M | 71.1M | 65.4M | 52.9M | 42.7M | 28.1M | 5.6M | |
| Earnings Per Share Basic | $-1.91 | $-2.33 | $-4.47 | $-4.48 | $-3.72 | $-4.19 | ||
| Common Stock Shares Outstanding | 69.1M | 71.3M | 70.8M | 59.3M | 45.5M | 41.0M | 5.2M | |
| Common Stock Shares Issued | 69.1M | 71.3M | 70.8M | 59.3M | 45.5M | 41.0M | 5.2M | |
| Common Stock Shares Authorized | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.37 | -$0.37 | -$0.67 | -$0.56 | -$1.24 | $0.14 | -$0.79 | -$1.85 | -$1.07 | -$0.96 | -$1.34 | -$1.31 | -$1.11 | -$0.09 | -$1.34 | -$1.24 | -$1.01 | -$0.91 | -$0.78 | -$2.88 | -$1.49 |
| Weighted Average Number Of Shares Outstanding Basic | 72.1M | 72.0M | 71.7M | 71.1M | 71.0M | 70.9M | 70.6M | 60.8M | 59.3M | 56.8M | 51.1M | 45.2M | 45.0M | 44.6M | 40.7M | 40.4M | 39.9M | 38.0M | 34.4M | 5.6M | |
| Weighted Average Number Of Diluted Shares Outstanding | 72.1M | 72.0M | 71.7M | 71.1M | 71.0M | 71.2M | 70.6M | 60.8M | 59.3M | 56.8M | 51.1M | 45.2M | 45.0M | 44.6M | 40.7M | 40.4M | 39.9M | 38.0M | 34.4M | 5.6M | |
| Earnings Per Share Basic | $-0.37 | $-0.37 | $-0.67 | $-0.56 | $-1.24 | $0.14 | $-0.79 | $-1.85 | $-1.07 | $-0.96 | $-1.34 | $-1.31 | $-1.11 | $-0.09 | $-1.34 | $-1.24 | $-1.01 | $-0.91 | $-0.78 | $-2.88 | |
| Common Stock Shares Outstanding | 72.2M | 72.1M | 72.0M | 71.1M | 71.1M | 71.0M | 70.6M | 70.6M | 59.4M | 57.0M | 57.0M | 45.6M | 45.2M | 41.3M | 41.0M | 40.6M | 35.9M | ||||
| Common Stock Shares Issued | 72.2M | 72.1M | 72.0M | 71.1M | 71.1M | 71.0M | 70.6M | 70.6M | 59.4M | 57.0M | 57.0M | 45.6M | 45.2M | 41.3M | 41.0M | 40.6M | 35.9M | ||||
| Common Stock Shares Authorized | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $20.7M | $67.3M | $54.8M | $46.8M | $35.7M | $23.1M | $617.0K |
| Investment And Other Income Expense | $16.2M | $25.5M | $22.6M | $6.0M | $401.0K | $683.0K | $482.0K |
| Additional Paid In Capital | $1.41B | $1.39B | $1.32B | $1.03B | $723.6M | $509.3M | |
| Stock Issued During Period Value Employee Stock Purchase Plan | $304.0K | $340.0K | $628.0K | $874.0K | $545.0K | ||
| Stock Issued During Period Value Stock Options Exercised | $8.0K | $995.0K | $2.2M | $7.1M | |||
| Deconsolidation Gain Or Loss Amount | $0.00 | $79.0K | $0.00 | $0.00 | $51.6M | $0.00 | $0.00 |
| Stock Issued During Period Value New Issues | $5.4M | $235.7M | $257.9M | $172.0M | $155.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $4.8M | $6.3M | $6.5M | $10.4M | $12.7M | $12.8M | $13.9M | $13.3M | $13.7M | $10.3M | $16.8M | $10.1M | $7.7M | $9.9M | $9.7M | $7.2M | $7.7M | $329.0K | $155.0K | $121.0K | $129.0K | |||
| Investment And Other Income Expense | $7.0M | $9.2M | -$2.7M | $11.2M | -$22.9M | $34.9M | $7.2M | $4.5M | $4.1M | $1.9M | $424.0K | $426.0K | $88.0K | $99.0K | $115.0K | $99.0K | $315.0K | $120.0K | $84.0K | $164.0K | $359.0K | $12.0K | $49.0K | $62.0K |
| Additional Paid In Capital | $1.41B | $1.40B | $1.40B | $1.36B | $1.35B | $1.34B | $1.31B | $1.30B | $1.05B | $972.1M | $961.2M | $735.0M | $702.9M | $529.0M | $519.0M | $501.5M | $339.2M | $0.00 | ||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $115.0K | $189.0K | $92.0K | $248.0K | $255.0K | $373.0K | $262.0K | $612.0K | $545.0K | |||||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $8.0K | $54.0K | $941.0K | $327.0K | $158.0K | $645.0K | $3.4M | $70.0K | ||||||||||||||||
| Deconsolidation Gain Or Loss Amount | $0.00 | $79.0K | $0.00 | $0.00 | $0.00 | $51.6M | $0.00 | $0.00 | $0.00 | |||||||||||||||
| Stock Issued During Period Value New Issues | $235.7M | $209.3M | $162.2M | $155.3M | $172.4M |
Most recent annual filing with the SEC: March 26, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.